Donald Trump's initiative to prioritize American-made prescription drugs poses significant challenges for Indian pharmaceutical companies. The policy shift aims to reshore drug manufacturing ...

(Reuters) -The U.S. Patent and Trademark Office has refused Tesla's attempt to trademark the term "Robotaxi" in reference to its vehicles, TechCrunch reported on Wednesday, citing a filing.

Tesla’s attempt to trademark the term “Robotaxi” in reference to its vehicles has been refused by the U.S. Patent and Trademark Office for being too generic, according to a new filing.

The three-daily capsules are aimed at balancing hormones with vitamin B6 and evening primrose oil; improving mental clarity and energy levels with ginseng and vitamin B12; plus supporting ...

For an accessible version of this Press Release, please visit www.tevapharm.com Duvakitug (Anti-TL1A) Phase 3 ready; program initiation expected in H2 2025; preparing for olanzapine LAI FDA NDA ...

For an accessible version of this Press Release, please visit www.tevapharm.com (1) Revised 2025 outlook now includes no contribution from the Japan BV after Q1 and continues to include a full ...

This increase was mainly due to higher revenues from AUSTEDO in our United States segment, from generic products in all our segments, from AJOVY in all our segments, as well as from UZEDY in our U ...

Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

Both generic and innovator companies have tried ... to manufacture than the normal solid dose formulations (tablets and capsules). For example injectables, patches and inhalers restrict the ...

Riss et al. [37] described the administration of extended-release carbamazepine capsules through the feeding tube in children. Capsule contents were mixed with 15 mL of water, and tube flushes ...